Skip to main content

Table 3 Tolerance

From: Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

 

Non-compliant

Compliant

Total

 

N

%

N

%

N

%

Very bad

9

14.3

9

10.1

18

11.8

Bad

10

15.9

8

9.0

18

11.8

Indifferent

13

20.6

29

32.6

42

27.6

Good

21

33.3

27

30.3

48

31.6

Very good

10

15.9

16

18.0

26

17.1

Total

63

100.0

89

100.0

152

100.0